These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 15231158)
41. Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan. Avazova D; Kurbanov F; Tanaka Y; Sugiyama M; Radchenko I; Ruziev D; Musabaev E; Mizokami M J Med Virol; 2008 Feb; 80(2):217-24. PubMed ID: 18098129 [TBL] [Abstract][Full Text] [Related]
42. [A cross-sectional survey on hepatitis B among general population in areas along Yangzi River in Anhui province]. Zhou LH; Li XQ; Ye DQ; Zheng YJ; Ge FY; Cai B; Huang F Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):144-6. PubMed ID: 19565874 [TBL] [Abstract][Full Text] [Related]
43. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine]. Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590 [TBL] [Abstract][Full Text] [Related]
44. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases. Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833 [TBL] [Abstract][Full Text] [Related]
45. Benefits of early hepatitis B immunization programs for newborns and infants. Van Herck K; Van Damme P Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823 [TBL] [Abstract][Full Text] [Related]
46. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005). Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034 [TBL] [Abstract][Full Text] [Related]
47. Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine. Adwan K; Abu-Hasan N; Adwan G; Abu-Khater K East Mediterr Health J; 2005 May; 11(3):494-8. PubMed ID: 16602472 [TBL] [Abstract][Full Text] [Related]
48. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization. Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839 [TBL] [Abstract][Full Text] [Related]
49. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia. Jaber SM Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474 [TBL] [Abstract][Full Text] [Related]
50. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age]. Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073 [TBL] [Abstract][Full Text] [Related]
51. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E; Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332 [TBL] [Abstract][Full Text] [Related]
52. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children. Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363 [TBL] [Abstract][Full Text] [Related]
53. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China]. Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882 [TBL] [Abstract][Full Text] [Related]
54. [Survey on seroepidemiological status and vaccine coverage of hepatitis B among children in Chaoyang district of Beijing in 2010]. Wang H; Zhang W; Ma JX; Li LQ; Zhang XC; Li SM; Wu K; Li Q; Liu XY; Pang XH Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Mar; 47(3):223-6. PubMed ID: 23866747 [TBL] [Abstract][Full Text] [Related]
55. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant. Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695 [TBL] [Abstract][Full Text] [Related]
56. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination. Papaevangelou V; Hadjichristodoulou C; Cassimos DC; Pantelaki K; Tzivaras A; Hatzimichael A; Theodoridou M Infection; 2008 Mar; 36(2):135-9. PubMed ID: 18231718 [TBL] [Abstract][Full Text] [Related]
57. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. Mu SC; Lin YM; Jow GM; Chen BF J Hepatol; 2009 Feb; 50(2):264-72. PubMed ID: 19070923 [TBL] [Abstract][Full Text] [Related]
58. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination. Salleras L; Domínguez A; Bruguera M; Plans P; Costa J; Cardeñosa N; Batalla J; Plasència A Vaccine; 2007 Dec; 25(52):8726-31. PubMed ID: 18045753 [TBL] [Abstract][Full Text] [Related]
59. Accelerated versus classical hepatitis B virus vaccination programs in healthcare workers accelerated vs. classical HBV vaccination. Tarhan MO; Aker AI; Sipahi OR; Kardes G; Biberoglu K Med Sci Monit; 2006 Nov; 12(11):CR467-70. PubMed ID: 17072271 [TBL] [Abstract][Full Text] [Related]
60. [Vaccination against hepatitis B. The 1988-1991 experience at Local Health District 9, Lombardy]. Gariboldi G Ann Ig; 1993; 5(3):199-205. PubMed ID: 7513177 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]